Alexion, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development.
Global Patient Safety (GPS) provides continuous and proactive assessment, management, and communication of patient risks associated with Alexion products. The department aims to optimize patient safety while complying with global regulatory requirements, being supported by an agile organization, and exemplifying rigorous process management.
The Alexion GPS Fellowship will provide the fellow with the opportunity to:
Develop the ability to think strategically and understand the role of Patient Safety in the lifecycle of products
Understand the benefit/risk balance of orphan drugs designed to treat devastating diseases
Cultivate and utilize knowledge in international pharmacovigilance regulations and guidelines, to increase process effectiveness
Participate and engage in cross-functional team projects involving Commercial, Marketing, Medical Affairs, and Regulatory Affairs to disseminate Global Patient Safety messages
Utilize scientific knowledge and research skills to support safety surveillance and risk management decisions
Develop skills to communicate complex safety messages cross-functionally and influence decision making
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS SMApply application portal. Visit mcphs.smapply.io
The portal will open on October 2, 2023.
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
ASHP attendance is not required but highly recommended for in-person interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal by November 17, 2023:
Letter of intent
Unofficial college transcript
Contact information of three references for their recommendations.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendations must be submitted by the three provided contacts no later than November 27, 2023, via the online portal. This is not a letter of recommendation but an online form that the reference will need to complete.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Alexion, AstraZeneca’s Rare Disease group, was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines as well as supportive technologies and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion leads with the knowledge that patients and caregivers are people first, and by seeking to understand their experiences, Alexion is better able to serve their unique needs.
Alexion’s pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion continues to push the boundaries of science to accelerate the discovery and development of new life-changing medicines for even more people affected by rare diseases. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and continues to expand its reach to benefit the lives of more rare disease patients around the world.
MCPHS provides an academic environment to guide and support fellows toward a successful career ...in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS offers programs that embody scholarship, professional service, and community outreach.
Through MCPHS, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to: develop, coordinate, and teach courses; co-precept pharmacy students on advanced experiential rotations; create and publish scholarly research and/or review articles; present research at scientific and clinical meetings; participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs.